John R Fischer

PE backs primary care digitalization push: 6 deals

Apollo, Arsenal, Kain Capital and OMERS Private Equity are among the PE firms that have invested in primary care.

PE targets radiology assets: 5 deals

Archimed, HCAP, Hg and Kain Capital are among the PE firms pursuing transactions in the radiology sector.

How a decade of pharma digitalization drove Nordic's $8.9bn sale of Clario to Thermo Scientific

'The sale to Thermo Fisher Scientific was the single biggest full exit in private equity globally announced last year,' Daniel Berglund, partner and head of healthcare at Nordic Capital, told PE Hub.

Sector Spotlight: Healthcare investors seek winners amid tech transformation and reimbursement shake-up

PE Hub spoke with senior private equity dealmakers from Arlington Capital Partners, Bain Capital, EQT, HIG Capital, Mérieux Equity Partners, One Equity Partners, Permira, the Vistria Group and WindRose Health Investors about the trends driving healthcare deals.

General Atlantic, Aquitaine, Avesi, PPC Enterprises target speech therapy; Stable pharmaceutical demand leads SK Capital-backed Apotex to C$1.3bn IPO

Early intervention is leading to more diagnoses in children of conditions that require speech therapy, fueling demand in the segment and catching the eye of private equity; discussing the largest life sciences IPO in the Toronto Stock Exchange’s history, launched by SK Capital-backed Apotex.

PE pursues pediatric speech therapy assets: 5 deals

General Atlantic, Aquitaine Capital, Avesi Partners and PPC Enterprises are among the PE firms investing in pediatric speech therapy.

Warburg, Martis, MKH Capital eye substance use care assets; Outpatient radiology demand drives Kain Capital’s investment in RadX

Exploring trends attracting firms such as Warburg Pincus, Martis Capital and MKH Capital to the substance use disorder sector; a look into a recent investment by Kain Capital in the outpatient radiology sector.

PE targets substance use care: 5 deals

Warburg Pincus, Frazier Healthcare Partners, Lee Equity and Sheridan are among the PE firms investing in the substance use care assets.

Exclusive: Sheridan Capital Partners takes majority stake in Tres Health

'You're going to see more investment in the self-insured space. That's the best way for employers to control their cost,' Sheridan's Chris McCrory told PE Hub.

Kinderhook’s Matt Bubis reveals Enhabit consolidation plans; AEA, Bridgepoint, Kohlberg eye oncology

A deep dive into Kinderhook Industries’ entry into the hospice care segment; private equity interest in the oncology sector; a look at Align Capital Partners’ investment in a mobile diagnostic imaging service provider; Baker Donelson’s Toni Peck on why PE dealmakers should pay attention to academic medical centers.